Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      Vaccine makers told to follow AstraZeneca’s lead to overcome 'grotesque' inequity
      Malaysiakini
      World
      Vaccine makers told to follow AstraZeneca’s lead to overcome 'grotesque' inequity

      Vaccine makers told to follow AstraZeneca’s lead to overcome 'grotesque' inequity

      ReutersPublished: Mar 23, 2021 2:21 AM

      More producers of Covid-19 vaccines should follow AstraZeneca’s lead and license technology to other manufacturers, the World Health Organization’s head said on Monday, as he described continuing vaccine inequity as “grotesque”.

      AstraZeneca’s shot, which new US data on Monday showed was safe and effective despite some countries suspending inoculations over health concerns, is being produced in various locations including South Korea’s SKBioScience and the Serum Institute of India.

      AstraZeneca vaccine safe and effective in US, Chile, Peru trials

      AstraZeneca vaccine safe and effective in US, Chile, Peru trials

      Europe aims to get vaccinations back on track after clearing AstraZeneca shot

      Europe aims to get vaccinations back on track after clearing AstraZeneca shot

      Germany, France among nations to resume use of AstraZeneca vaccine

      Germany, France among nations to resume use of AstraZeneca vaccine

      EU's drug regulator backs 'safe and effective' AstraZeneca vaccine

      EU's drug regulator backs 'safe and effective' AstraZeneca vaccine

      China vaccine jabs begin

      China vaccine jabs begin

      It's 'an quan', KJ declares after taking Sinovac vaccine

      It's 'an quan', KJ declares after taking Sinovac vaccine

      How worried should we be about negative reports of AstraZeneca's vaccine?

      How worried should we be about negative reports of AstraZeneca's vaccine?

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports7

      AstraZeneca vaccine safe and effective in US, Chile, Peru trials

      22-03-2021

      Europe aims to get vaccinations back on track after clearing AstraZeneca shot

      20-03-2021

      Germany, France among nations to resume use of AstraZeneca vaccine

      19-03-2021

      EU's drug regulator backs 'safe and effective' AstraZeneca vaccine

      18-03-2021

      China vaccine jabs begin

      18-03-2021

      It's 'an quan', KJ declares after taking Sinovac vaccine

      18-03-2021

      How worried should we be about negative reports of AstraZeneca's vaccine?

      17-03-2021
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor